image
Qiagen N.V. QGEN
Healthcare - Medical - Diagnostics & Research - NYSE - NL
Watchlist
$ 42.63
-1.49 %
$ 9.21 B
Market Cap
110.97
P/E
INCOME STATEMENT
1.98 B REVENUE
0.66%
Growth Rates
1Year 0.66%
3Years -4.22%
5Years 5.32%
7Years 4.88%
10Years 3.94%
97.7 M OPERATING INCOME
-78.05%
Growth Rates
1Year -78.05%
3Years -46.27%
5Years -21.90%
7Years -6.24%
10Years -4.86%
83.6 M NET INCOME
-75.51%
Growth Rates
1Year -75.51%
3Years -45.37%
5Years 32.06%
7Years 10.95%
10Years -3.32%
EFFICIENCY
Earnings Waterfall Qiagen N.V.
image
Revenue 1.98 B
Cost Of Revenue 653 M
Gross Profit 1.32 B
Operating Expenses 1.23 B
Operating Income 97.7 M
Other Expenses 14.1 M
Net Income 83.6 M
2b2b2b2b2b2b1b1b1b1b1b1b800m800m600m600m400m400m200m200m002b(653m)1b(1b)98m(14m)84mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995
REVENUE
Revenue 1 978.2 1 965.3 2 141.5 2 251.7 1 870.3 1 526.4 1 501.8 1 417.5 1 338.0 1 281.0 1 344.8 1 302.0 1 254.5 1 169.7 1 087.4 1 009.8 893.0 649.8 465.8 398.4 380.6 351.4 298.6 263.8 204.0 144.0 110.2 74.3 54.2 37.0
GROSS PROFIT
Cost Of Revenue 653.4 742.4 757.0 800.8 642.5 521.2 500.9 495.0 493.3 454.6 479.8 486.5 430.4 419.9 371.9 342.8 293.3 216.2 141.2 123.2 127.1 122.4 96.5 79.7 49.0 32.1 27.0 15.1 12.2 7.7
Gross Profit 1 324.8 1 222.9 1 384.6 1 450.8 1 227.8 1 005.3 1 001.0 922.6 844.7 826.4 864.9 815.5 824.0 749.8 715.6 667.1 599.7 433.5 324.6 275.2 253.5 229.0 202.1 184.1 155.1 111.8 83.2 59.2 42.0 29.3
OPERATING INCOME
Operating Expenses 1 227.1 777.7 808.3 793.0 682.9 691.6 734.4 769.1 745.8 650.7 704.1 752.2 654.2 650.2 527.0 486.9 438.7 301.6 214.3 173.9 165.0 157.1 145.3 130.6 104.4 85.4 68.6 50.9 36.0 24.6
Selling, General and Administrative Expenses 564.4 579.2 603.9 584.5 544.3 504.2 533.5 575.7 530.6 464.8 503.4 570.6 495.6 492.8 377.5 360.7 341.3 236.6 164.5 134.8 129.2 125.3 117.1 100.9 82.2 61.3 50.0 37.7 27.0 18.4
Research and Development Expenses 193.5 198.5 189.9 190.0 139.1 157.4 161.9 154.1 176.1 147.2 163.6 146.1 122.5 130.6 126.0 107.9 97.3 64.9 41.6 39.1 34.2 31.8 28.2 26.8 22.2 16.3 12.8 8.3 6.5 4.4
Operating Income 97.7 445.2 531.5 630.1 554.9 336.2 266.6 153.4 98.8 175.7 160.8 63.3 169.8 99.6 188.5 180.2 145.7 83.1 100.6 94.8 84.1 68.9 43.2 53.5 34.9 26.5 14.6 8.3 6.0 4.7
PRE-TAX INCOME
Interest Income Expense 43.8 53.4 58.4 54.5 73.0 74.2 67.3 49.7 39.0 37.4 39.3 30.9 23.5 25.4 27.8 29.6 37.5 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 23.4 (15.4) (18.9) (4.3) 53.0 (51.6) (40.8) (39.0) (41.9) (43.2) (41.4) (26.0) (24.7) (3.4) (15.4) (7.9) (26.4) (51.4) (6.3) (4.5) (17.3) (1.6) (4.3) 2.8 2.6 1.5 2.7 5.3 2.6 (0.2)
Pre-Tax Income 121.1 429.8 512.6 625.8 154.9 (77.8) 225.7 114.4 56.9 132.5 118.5 37.3 145.2 96.2 173.1 172.3 119.3 75.7 106.1 97.3 72.7 67.3 38.9 56.3 37.1 23.0 17.5 13.6 8.6 4.5
NET INCOME
Tax Provision 37.6 88.5 89.4 113.2 81.3 (36.3) 35.4 74.0 (23.4) 5.6 1.3 (31.8) 15.6 1.3 28.8 34.6 29.8 25.6 35.5 35.0 24.0 24.4 15.7 21.9 17.0 10.3 5.1 4.8 3.3 2.1
Net Income 83.6 341.3 423.2 512.6 73.6 (41.5) 190.4 40.4 80.4 127.1 116.6 69.1 129.5 96.0 144.3 137.8 89.0 50.1 70.5 62.2 48.7 42.9 23.1 34.4 20.1 12.6 12.4 8.8 5.3 2.4
EPS 0.37 1.54 1.92 2.32 0.33 0.19 0.84 0.18 0.36 0.57 0.52 0.31 0.57 0.43 0.64 0.7 0.47 0.31 0.49 0.44 0.34 0.3 0.17 0.25 0.16 0.1 0.0935 0.0727 0.0519 0.0312